| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZ628 | GDSC1000 | pan-cancer | AAC | -0.074 | 0.1 |
| mRNA | BMS-708163 | GDSC1000 | pan-cancer | AAC | -0.05 | 0.1 |
| mRNA | PLX4720 | GDSC1000 | pan-cancer | AAC | -0.045 | 0.1 |
| mRNA | SKI-II | CTRPv2 | pan-cancer | AAC | -0.052 | 0.1 |
| mRNA | CHIR-99021 | GDSC1000 | pan-cancer | AAC | 0.046 | 0.1 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | -0.044 | 0.1 |
| mRNA | NVP-BSK805 | CTRPv2 | pan-cancer | AAC | 0.047 | 0.2 |
| mRNA | Bryostatin 1 | GDSC1000 | pan-cancer | AAC | -0.051 | 0.2 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.039 | 0.2 |
| mRNA | BRD-K51831558 | CTRPv2 | pan-cancer | AAC | -0.073 | 0.2 |